| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |